These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 39101355)
21. Development and in vitro/in vivo evaluation of a novel benznidazole liquid dosage form using a quality-by-design approach. Santos Souza HF; Real D; Leonardi D; Rocha SC; Alonso V; Serra E; Silber AM; Salomon CJ Trop Med Int Health; 2017 Dec; 22(12):1514-1522. PubMed ID: 28944986 [TBL] [Abstract][Full Text] [Related]
22. Successful Aspects of the Coadministration of Sterol 14α-Demethylase Inhibitor VFV and Benznidazole in Experimental Mouse Models of Chagas Disease Caused by the Drug-Resistant Strain of Trypanosoma cruzi. Guedes-da-Silva FH; Batista DDGJ; Da Silva CF; Pavão BP; Batista MM; Moreira OC; Souza LRQ; Britto C; Rachakonda G; Villalta F; Lepesheva GI; Soeiro MNC ACS Infect Dis; 2019 Mar; 5(3):365-371. PubMed ID: 30625275 [TBL] [Abstract][Full Text] [Related]
23. Looking for combination of benznidazole and Trypanosoma cruzi-triosephosphate isomerase inhibitors for Chagas disease treatment. Aguilera E; Varela J; Serna E; Torres S; Yaluff G; Bilbao NV; Cerecetto H; Alvarez G; González M Mem Inst Oswaldo Cruz; 2018 Mar; 113(3):153-160. PubMed ID: 29412353 [TBL] [Abstract][Full Text] [Related]
24. Anti-parasitic effect of vitamin C alone and in combination with benznidazole against Trypanosoma cruzi. Puente V; Demaria A; Frank FM; Batlle A; Lombardo ME PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006764. PubMed ID: 30240395 [TBL] [Abstract][Full Text] [Related]
25. Extemporaneous benznidazole oral suspension prepared from commercially available tablets for treatment of Chagas disease in paediatric patients. García MC; Manzo RH; Jimenez-Kairuz AF Trop Med Int Health; 2015 Jul; 20(7):864-70. PubMed ID: 25784402 [TBL] [Abstract][Full Text] [Related]
26. Benznidazole Nanoformulates: A Chance to Improve Therapeutics for Chagas Disease. Vinuesa T; Herráez R; Oliver L; Elizondo E; Acarregui A; Esquisabel A; Pedraz JL; Ventosa N; Veciana J; Viñas M Am J Trop Med Hyg; 2017 Nov; 97(5):1469-1476. PubMed ID: 29016287 [TBL] [Abstract][Full Text] [Related]
27. Benznidazole in Cerebrospinal Fluid: a Case Series of Chagas Disease Meningoencephalitis in HIV-Positive Patients. Fernández ML; Marson ME; Mastrantonio GE; Corti MA; Fleitas U; Lloveras SC; Lista N; Priarone MM; Domínguez C; Garcia-Bournissen F Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361290 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of novel benznidazole solutions during the experimental infection with Trypanosoma cruzi. Manarin R; Lamas MC; Bottasso E; Serra E; Revelli S; Salomón CJ Parasitol Int; 2013 Feb; 62(1):79-81. PubMed ID: 22975280 [TBL] [Abstract][Full Text] [Related]
29. A study of photostability and compatibility of the anti-chagas drug Benznidazole with pharmaceutics excipients. Santos FL; Rolim LA; Figueirêdo CB; Lyra MA; Peixoto MS; Ferraz LR; Soares-Sobrinho JL; Neves de Lima ÁA; Lima Leite AC; Rolim Neto PJ Drug Dev Ind Pharm; 2015 Jan; 41(1):63-9. PubMed ID: 24134564 [TBL] [Abstract][Full Text] [Related]
30. Multi-kinetic release of benznidazole-loaded multiparticulate drug delivery systems based on polymethacrylate interpolyelectrolyte complexes. García MC; Martinelli M; Ponce NE; Sanmarco LM; Aoki MP; Manzo RH; Jimenez-Kairuz AF Eur J Pharm Sci; 2018 Jul; 120():107-122. PubMed ID: 29705213 [TBL] [Abstract][Full Text] [Related]
31. Low-dose of benznidazole promotes therapeutic cure in experimental chronic Chagas' disease with absence of parasitism in blood, heart and colon. Perin L; Fonseca KDS; de Carvalho TV; Carvalho LM; Madeira JV; Medeiros LDF; Molina I; Correa-Oliveira R; Carneiro CM; Vieira PMA Exp Parasitol; 2020 Mar; 210():107834. PubMed ID: 31978394 [TBL] [Abstract][Full Text] [Related]
32. Frequency Variation and Dose Modification of Benznidazole Administration for the Treatment of Trypanosoma cruzi Infection in Mice, Dogs, and Nonhuman Primates. Bustamante JM; White BE; Wilkerson GK; Hodo CL; Auckland LD; Wang W; McCain S; Hamer SA; Saunders AB; Tarleton RL Antimicrob Agents Chemother; 2023 May; 67(5):e0013223. PubMed ID: 37039666 [TBL] [Abstract][Full Text] [Related]
33. Development of effervescent tablets containing benzonidazole complexed with cyclodextrin. Maximiano FP; Costa GH; de Sá Barreto LC; Bahia MT; Cunha-Filho MS J Pharm Pharmacol; 2011 Jun; 63(6):786-93. PubMed ID: 21585376 [TBL] [Abstract][Full Text] [Related]
34. The impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection. Nguyen DM; Poveda C; Pollet J; Gusovsky F; Bottazzi ME; Hotez PJ; Jones KM PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011519. PubMed ID: 37988389 [TBL] [Abstract][Full Text] [Related]
35. Trypanosoma cruzi: Does the intake of nanoencapsulated benznidazole control acute infections? Dutra da Silva A; Fracasso M; Bottari NB; Gundel S; Ourique AF; Assmann CE; Ferreira DASP; Castro MFV; Reichert KP; de Souza LAF; da Veiga ML; da Rocha MIUM; Monteiro SG; Morsch VM; Chitolina Schetinger MR; da Silva AS Exp Parasitol; 2023 Jun; 249():108520. PubMed ID: 37001581 [TBL] [Abstract][Full Text] [Related]
36. Benznidazole self-emulsifying delivery system: A novel alternative dosage form for Chagas disease treatment. Mazzeti AL; Oliveira LT; Gonçalves KR; Schaun GC; Mosqueira VCF; Bahia MT Eur J Pharm Sci; 2020 Mar; 145():105234. PubMed ID: 31978590 [TBL] [Abstract][Full Text] [Related]
37. Benznidazole vs benznidazole in multilamellar liposomes: how different they interact with blood components? Morilla MJ; Prieto MJ; Romero EL Mem Inst Oswaldo Cruz; 2005 Apr; 100(2):213-9. PubMed ID: 16021311 [TBL] [Abstract][Full Text] [Related]
38. In vitro trypanocidal activity of tetraethylthiuram disulfide and sodium diethylamine-N-carbodithioate on Trypanosoma cruzi. Lane JE; Ribeiro-Rodrigues R; Suarez CC; Bogitsh BJ; Jones MM; Singh PK; Carter CE Am J Trop Med Hyg; 1996 Sep; 55(3):263-6. PubMed ID: 8842112 [TBL] [Abstract][Full Text] [Related]
39. Novel nitroimidazole derivatives evaluated for their trypanocidal, cytotoxic, and genotoxic activities. do Vale Chaves E Mello F; Castro Salomão Quaresma BM; Resende Pitombeira MC; Araújo de Brito M; Farias PP; Lisboa de Castro S; Salomão K; Silva de Carvalho A; Oliveira de Paula JI; de Brito Nascimento S; Peixoto Cupello M; Paes MC; Boechat N; Felzenszwalb I Eur J Med Chem; 2020 Jan; 186():111887. PubMed ID: 31787363 [TBL] [Abstract][Full Text] [Related]
40. Novel polymorphs of the anti-Trypanosoma cruzi drug benznidazole. Honorato SB; Mendonça JS; Boechat N; Oliveira AC; Mendes Filho J; Ellena J; Ayala AP Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jan; 118():389-94. PubMed ID: 24076454 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]